Form 4 for CC Chemours Co
Accepted 2023-06-09 00:00:00 ET · period of report 2023-06-08 · accession 0001209191-23-035921 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2023-06-09 | 2023-06-08 | CC | Abbott Matthew S | SVP, Chief Enterprise Transfor | S - Sale+OE | $34.20 | -8,912 | 29.9K | -23% | -$304.8K |
| D | 2023-06-09 | 2023-06-08 | CC | Abbott Matthew S | SVP, Chief Enterprise Transfor | M - OptEx | $14.43 | +8,912 | 38.8K | +30% | +$128.6K |
| D | 2023-06-09 | 2023-06-08 | CC | Abbott Matthew S | SVP, Chief Enterprise Transfor | M - OptEx | $0.00 | -8,912 | 0 | -100% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2023-06-08 | S | D | 8,912 | $34.20 | 29,869.12 | D | — | — | (F2) Shares were sold in multiple transactions at a price of $34.20. (F1) Includes directly owned shares, restricted stock units and dividend equivalent units. |
| 2 | Common | Common Stock | 2023-06-08 | M | A | 8,912 | $14.43 | 38,781.12 | D | — | — | (F1) Includes directly owned shares, restricted stock units and dividend equivalent units. |
| 3 | Derivative | Stock Option (Right to Buy) | 2023-06-08 | M | D | 8,912 | $0.00 | 0 | D | $14.43 · — to 2030-03-02 | 8,912 Common Stock | (F3) Option award was granted on March 2, 2020 with vesting in three equal annual installments beginning March 2, 2021. |